Skip to the page

Data / Drug companies / Aminocaproic acid

Aminocaproic acid: 23 companies and 37 products in the FDA NDC directory

Aminocaproic acid is listed in the FDA National Drug Code Directory by 23 companies, with 37 products in commercial distribution. 35 of the products (94.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution; injection, solution, and the newest product started marketing on September 20, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
23
Products
37
Generic (ANDA) products
35 (94.6%)
Application numbers
19
Routes
Oral, Intravenous
openFDA record search
api.fda.gov

Companies that list aminocaproic acid

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Biocon Pharma Inc.3tablet; solutionGeneric drugs (ANDA)March 18, 2021
Carnegie Pharmaceuticals LLC3tablet; solutionGeneric drugs (ANDA)March 18, 2021
Novadoz Pharmaceuticals LLC3tablet; solutionGeneric drugs (ANDA)September 26, 2024
Vitruvias Therapeutics3tablet; solutionGeneric drugs (ANDA)July 19, 2024
American Regent, Inc.2injection, solutionGeneric drugs (ANDA)February 1, 2019
Amneal Pharmaceuticals NY LLC2solution; tabletGeneric drugs (ANDA)November 30, 2019
Hikma Pharmaceuticals USA Inc.2syrup; tabletAuthorized generics (NDA)March 12, 2019
Medical Purchasing Solutions, LLC2injection, solutionGeneric drugs (ANDA)May 12, 2010
Puracap Laboratories LLC DBA Blu Pharmaceuticals2tabletGeneric drugs (ANDA)January 24, 2023
Rising Pharma Holdings, Inc.2tabletGeneric drugs (ANDA)September 20, 2026
American Health Packaging1tabletGeneric drugs (ANDA)March 10, 2023
Apozeal Pharmaceuticals Inc1solutionGeneric drugs (ANDA)November 10, 2025
Aurobindo Pharma Limited1solutionGeneric drugs (ANDA)September 26, 2022
Bpi Labs LLC1solutionGeneric drugs (ANDA)May 16, 2022
Bryant Ranch Prepack1solutionGeneric drugs (ANDA)March 18, 2021
Camber Pharmaceuticals, Inc.1solutionGeneric drugs (ANDA)November 4, 2022
Civica, Inc.1injection, solutionGeneric drugs (ANDA)October 29, 2020
Florida Pharmaceutical Products, LLC1solutionGeneric drugs (ANDA)December 20, 2025
Henry Schein, Inc.1injection, solutionGeneric drugs (ANDA)October 26, 2021
Hospira, Inc.1injection, solutionGeneric drugs (ANDA)May 12, 2010
Kesin Pharma Corporation1tabletGeneric drugs (ANDA)December 10, 2020
Major Pharmaceuticals1tabletGeneric drugs (ANDA)November 30, 2019
TruPharma, LLC1solutionGeneric drugs (ANDA)September 25, 2020

Dosage forms

Dosage formProductsShare
Tablet1745.9%
Solution1232.4%
Injection, solution718.9%
Syrup12.7%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3594.6%
Authorized generics (NDA)25.4%

Pharmacologic classes

ClassProducts
Antifibrinolytic Agent37

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.